Dysfunctional Telomeres, Checkpoints and Aging
Dysfunctional Telomeres, Checkpoints and Aging
批准号:
7065017
负责人:
Kwok Kin Wong
金额:
$28.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2011-08-31
关键词:
DNA repairagingantineoplasticsapoptosisataxia telangiectasiacell agecell differentiationchemopreventiondevelopmental geneticsgene mutationgenetically modified animalshistopathologylaboratory mouseneoplasm /cancer epidemiologyneoplasm /cancer geneticsneoplasm /cancer pharmacologyneoplastic transformationoxidative stressp53 gene /proteinstem cellstamoxifentelomerasetelomeretissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Telomeres are specialized capping structures on chromosomes that play important roles in aging, cancer and genome stability. With each cell division, telomeres progressively shorten such that upon reaching a critical stage, they signal cells to stop dividing. This process likely prevents cells from acquiring mutations that may result in cancer or aging. When mutations occur in crucial genes that regulate telomere maintenance or checkpoint responses (such as p53 and ATM), telomeres become critically shortened and dysfunctional. Our recent findings linking telomere dysfunction to precursor/stem cell depletion and accelerated aging in the combined telomerase Atm mutant mouse model provide a unique opportunity and genetic platform to explore the molecular mechanisms by which telomere dysfunction contributes to aging, organ homeostasis and tumorigenesis. We hypothesize that mice engineered to have critically short telomeres and defective checkpoint responses due to mTerc and Atm deficiency will be predisposed to either accelerated aging or tumorigenesis depending on p53 status. We also believe that reconstitution of telomerase activity in different organ compartments of these mice will, depending on the state of the genome at the time of the reconstitution, either strongly promote organ specific tumor progression or rescue the organ stem/progenitor cell depletion phenotype as well as suppressing tumorigenesis. Lastly, detailed molecular characterization of pathways leading to activation of p53 function in primary cells and tissues from these compound mutant mice with accelerated aging and precursor/stem cell depletion will dissect the molecular pathways that are involved in the process of aging and organ homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
-
批准号:9451116
-
项目类别:
-
资助金额:$55.92万
-
财政年份:2017
-
负责人:Kwok Kin Wong
-
依托单位:
Animal Models/Experimental Therapeutics Core
-
批准号:8237138
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2012
-
负责人:Kwok Kin Wong
-
依托单位:
Core C: Animal Modeling and Preclinical Therapeutics
-
批准号:10231104
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2012
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7653672
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8450878
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8826566
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7428779
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7484951
-
项目类别:
-
资助金额:$27.08万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7269241
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7130431
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7837568
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
-
批准号:7621014
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8640891
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7289887
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Dysfunctional Telomeres, Checkpoints and Aging
-
批准号:7910424
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8108668
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
-
批准号:8332284
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2006
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6804430
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6945778
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
Modeling Lung Cancer in Telomerase Null Mice
-
批准号:6617124
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Kwok Kin Wong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: